DASAMI LAB PRIVATE LTD

DASAMI LAB PRIVATE LTD (India) holds 32 active US FDA Type II Drug Master Files, has DMF or CEP filings on record for 28 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “DASAMI LAB PRIVATE LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/dasami-lab-private-ltd

Overview

DASAMI LAB PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 32 active FDA Type II Drug Master Files, covering AMINOCAPROIC ACID; CANAGLIFLOZIN (AMORPHOUS); CANAGLIFLOZIN HEMIHYDRATE; CARBAMAZEPINE USP; CHLORPROMAZINE HYDROCHLORIDE USP; DEXTROMETHORPHAN HYDROBROMIDE USP.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which DASAMI LAB PRIVATE LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

DASAMI LAB PRIVATE LTD holds 32 active (32 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • MYCOPHENOLATE MOFETIL USPActive2025-11-14
  • DEXTROMETHORPHAN POLISTIREXActive2025-08-30
  • THEOPHYLLINE ANHYDROUS USPActive2025-07-29
  • MAVACAMTENActive2025-03-25
  • VILOXAZINE HYDROCHLORIDEActive2024-12-20
  • MIDODRINE HYDROCHLORIDE USPActive2024-08-23
  • FEBUXOSTATActive2024-01-24
  • SUVOREXANT (FORM-II)Active2023-10-25
  • LUMATEPERONE TOSYLATEActive2023-07-22
  • PITOLISANT HYDROCHLORIDEActive2023-05-09
  • MESALAMINE USPActive2022-12-02
  • DEXTROMETHORPHAN HYDROBROMIDE USPActive2022-10-31
  • VERAPAMIL HYDROCHLORIDE USPActive2022-08-02
  • SPIRONOLACTONE USPActive2022-02-04
  • FLUVOXAMINE MALEATE USPActive2021-12-01
  • CARBAMAZEPINE USPActive2021-09-14
  • AMINOCAPROIC ACIDActive2021-06-15
  • ESLICARBAZEPINE ACETATE (PROCESS-II)Active2021-02-16
  • DROXIDOPA (PROCESS-II)Active2020-11-27
  • OXCARBAZEPINE USP (PROCESS-II)Active2020-09-30
  • CHLORPROMAZINE HYDROCHLORIDE USPActive2020-09-29
  • TRIENTINE HYDROCHLORIDEActive2020-08-28
  • PIMAVANSERIN TARTRATEActive2020-02-04
  • NITAZOXANIDEActive2019-07-26
  • GABAPENTIN ENACARBILActive2019-03-29
  • NIMODIPINEActive2018-10-01
  • RANOLAZINEActive2018-07-21
  • DROXIDOPAActive2017-12-08
  • ESLICARBAZEPINE ACETATEActive2017-08-24
  • OXCARBAZEPINE USPActive2017-04-17
  • CANAGLIFLOZIN HEMIHYDRATEActive2017-03-16
  • CANAGLIFLOZIN (AMORPHOUS)Active2016-11-18

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to DASAMI LAB PRIVATE LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to DASAMI LAB PRIVATE LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this DASAMI LAB PRIVATE LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.